Regulus Therapeutics Inc

NASDAQ RGLS

Download Data

Regulus Therapeutics Inc Share Price on June 03, 2024: USD 2.21

Regulus Therapeutics Inc Share Price is USD 2.21 on June 03, 2024, a 61.31% change year over year. Share price refers to the current trading price of a single share of a company's stock. It represents the monetary value that investors are willing to pay for ownership in the company. Share prices are determined by the supply and demand dynamics in the stock market and can fluctuate throughout the trading day. Changes in share prices are influenced by various factors, including company performance, industry trends, market conditions, investor sentiment, and economic indicators. Share price is a key indicator used by investors to assess the performance and valuation of a company's stock.
  • Regulus Therapeutics Inc 52-week high Share Price is USD 2.88 on March 28, 2024, which is 30.32% above the current Share Price.
  • Regulus Therapeutics Inc 52-week low Share Price is USD 1.13 on January 17, 2024, which is -48.87% below the current Share Price.
  • Regulus Therapeutics Inc average Share Price for the last 52 weeks is USD 1.62.
NASDAQ: RGLS

Regulus Therapeutics Inc

CEO Mr. Joseph P. Hagan M.B.A.
IPO Date Oct. 4, 2012
Location United States
Headquarters 4224 Campus Point Court, San Diego, CA, United States, 92121
Employees 30
Sector Healthcare
Industry Biotechnology
Description

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Similar companies

VSTM

Verastem Inc

NA

NA

PULM

Pulmatrix Inc

NA

NA

CLRB

Cellectar Biosciences Inc

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email